Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stuart Grant currently holds 196,485 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stuart Grant has been a net seller of BCRX stock. They have purchased $13.3K and sold $667.7K worth of shares.
Stuart Grant's most recent insider trade was on Aug 29, 2017, when they sold 566,603 shares at $35.00 per share.
Stuart Grant serves as Executive at BIOCRYST PHARMACEUTICALS INC (BCRX). They have executed 29 insider transactions totaling $681.0K over their tenure at the company.
Stuart Grant holds the position of Executive at BIOCRYST PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Stuart Grant has shown a selling trading pattern, with $13.3K in total purchases and $667.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Stuart Grant was on Aug 29, 2017, when they sold $19.8M worth of PTHN shares. This transaction involved 566,603 shares at $35.00 per share.
Stuart Grant currently owns 196,485 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stuart Grant's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stuart Grant has 29 Form 4 filings on record as an insider at BIOCRYST PHARMACEUTICALS INC.
Set alerts for Stuart Grant and 40,000+ other insiders.